162 related articles for article (PubMed ID: 8756801)
21. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
Pearlman DS
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):180-4. PubMed ID: 7648385
[TBL] [Abstract][Full Text] [Related]
22. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
Yates DH; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
[TBL] [Abstract][Full Text] [Related]
23. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
[TBL] [Abstract][Full Text] [Related]
24. Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.
Juniper EF; Johnston PR; Borkhoff CM; Guyatt GH; Boulet LP; Haukioja A
Am J Respir Crit Care Med; 1995 Jan; 151(1):66-70. PubMed ID: 7812574
[TBL] [Abstract][Full Text] [Related]
25. Maintaining asthma control in persistent asthma: comparison of three strategies in a 6-month double-blind randomised study.
Godard P; Greillier P; Pigearias B; Nachbaur G; Desfougeres JL; Attali V
Respir Med; 2008 Aug; 102(8):1124-31. PubMed ID: 18606533
[TBL] [Abstract][Full Text] [Related]
26. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma.
Shapiro G; Lumry W; Wolfe J; Given J; White MV; Woodring A; Baitinger L; House K; Prillaman B; Shah T
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):527-34. PubMed ID: 10673196
[TBL] [Abstract][Full Text] [Related]
27. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.
Simons FE
N Engl J Med; 1997 Dec; 337(23):1659-65. PubMed ID: 9385125
[TBL] [Abstract][Full Text] [Related]
28. Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids.
Vermetten FA; Boermans AJ; Luiten WD; Mulder PG; Vermue NA
J Asthma; 1999; 36(1):97-106. PubMed ID: 10077139
[TBL] [Abstract][Full Text] [Related]
29. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of salmeterol in childhood asthma.
Lenney W; Pedersen S; Boner AL; Ebbutt A; Jenkins MM
Eur J Pediatr; 1995 Dec; 154(12):983-90. PubMed ID: 8801107
[TBL] [Abstract][Full Text] [Related]
31. Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone.
Calhoun WJ; Nelson HS; Nathan RA; Pepsin PJ; Kalberg C; Emmett A; Rickard KA; Dorinsky P
Am J Respir Crit Care Med; 2001 Sep; 164(5):759-63. PubMed ID: 11549529
[TBL] [Abstract][Full Text] [Related]
32. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.
Fitzpatrick MF; Mackay T; Driver H; Douglas NJ
BMJ; 1990 Dec; 301(6765):1365-8. PubMed ID: 1980220
[TBL] [Abstract][Full Text] [Related]
33. Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies.
Faurschou P; Engel AM; Haanaes OC
Allergy; 1994 Dec; 49(10):827-32. PubMed ID: 7709991
[TBL] [Abstract][Full Text] [Related]
34. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases.
Murray JJ; Church NL; Anderson WH; Bernstein DI; Wenzel SE; Emmett A; Rickard KA
Allergy Asthma Proc; 1999; 20(3):173-80. PubMed ID: 10389550
[TBL] [Abstract][Full Text] [Related]
35. A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: a Canadian multicenter study.
Boulet LP; Laviolette M; Boucher S; Knight A; Hébert J; Chapman KR
J Allergy Clin Immunol; 1997 Jan; 99(1 Pt 1):13-21. PubMed ID: 9003206
[TBL] [Abstract][Full Text] [Related]
36. Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.
Taylor DR; Town GI; Herbison GP; Boothman-Burrell D; Flannery EM; Hancox B; Harré E; Laubscher K; Linscott V; Ramsay CM; Richards G
Thorax; 1998 Sep; 53(9):744-52. PubMed ID: 10319056
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.
Ulrik CS
Thorax; 1995 Jul; 50(7):750-4. PubMed ID: 7570409
[TBL] [Abstract][Full Text] [Related]
38. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.
Lundback B; Rawlinson DW; Palmer JB
Thorax; 1993 Feb; 48(2):148-53. PubMed ID: 8493629
[TBL] [Abstract][Full Text] [Related]
39. A 4-week comparison of salmeterol and terbutaline in adult asthma.
Hermansson BA; Jenkins RJ
Allergy; 1995 Jul; 50(7):551-8. PubMed ID: 8588686
[TBL] [Abstract][Full Text] [Related]
40. Proof-of-concept evaluation of trough airway hyper-responsiveness following regular racemic or levosalbutamol in genotype-stratified steroid-treated persistent asthmatic patients.
Anderson WJ; Short PM; Williamson PA; Morrison AE; Palmer C; Tavendale R; Lipworth BJ
Clin Sci (Lond); 2014 Jan; 126(1):75-83. PubMed ID: 23829494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
